Exogenous PIM1 expression similarly induced ruxolitinib resistance in 32D myeloid cells transformed by the MPN oncogenic protein Mpl-W515L (Supplementary Fig. 7). The gene discussed is PIM1; the disease is myeloproliferative disorder.